Bangladesh
· Delayed Price · Currency is BDT Central Pharmaceuticals Statistics
Total Valuation
DSE:CENTRALPHL has a market cap or net worth of BDT 1.79 billion. The enterprise value is 2.05 billion.
| Market Cap | 1.79B |
| Enterprise Value | 2.05B |
Important Dates
The last earnings date was Sunday, February 2, 2025.
| Earnings Date | Feb 2, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
DSE:CENTRALPHL has 119.80 million shares outstanding. The number of shares has decreased by -1.29% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 119.80M |
| Shares Change (YoY) | -1.29% |
| Shares Change (QoQ) | +2.83% |
| Owned by Insiders (%) | 25.89% |
| Owned by Institutions (%) | n/a |
| Float | 88.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 254.32 |
| PB Ratio | 2.11 |
| P/TBV Ratio | 2.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -56.44 |
| EV / Sales | 292.39 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.15, with a Debt / Equity ratio of 0.32.
| Current Ratio | 1.15 |
| Quick Ratio | 0.22 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -4.82% and return on invested capital (ROIC) is -2.34%.
| Return on Equity (ROE) | -4.82% |
| Return on Assets (ROA) | -1.78% |
| Return on Invested Capital (ROIC) | -2.34% |
| Return on Capital Employed (ROCE) | -3.48% |
| Revenue Per Employee | 94,851 |
| Profits Per Employee | -491,345 |
| Employee Count | 74 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 1.25 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.92% in the last 52 weeks. The beta is 0.09, so DSE:CENTRALPHL's price volatility has been lower than the market average.
| Beta (5Y) | 0.09 |
| 52-Week Price Change | -42.92% |
| 50-Day Moving Average | 10.05 |
| 200-Day Moving Average | 15.38 |
| Relative Strength Index (RSI) | 76.91 |
| Average Volume (20 Days) | 4,161,233 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DSE:CENTRALPHL had revenue of BDT 7.02 million and -36.36 million in losses. Loss per share was -0.30.
| Revenue | 7.02M |
| Gross Profit | -21.44M |
| Operating Income | -38.45M |
| Pretax Income | -43.00M |
| Net Income | -36.36M |
| EBITDA | -15.08M |
| EBIT | -38.45M |
| Loss Per Share | -0.30 |
Balance Sheet
The company has 1.25 million in cash and 268.47 million in debt, giving a net cash position of -267.23 million or -2.23 per share.
| Cash & Cash Equivalents | 1.25M |
| Total Debt | 268.47M |
| Net Cash | -267.23M |
| Net Cash Per Share | -2.23 |
| Equity (Book Value) | 844.84M |
| Book Value Per Share | 7.05 |
| Working Capital | 49.93M |
Cash Flow
| Operating Cash Flow | 2.46M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -547.78% |
| Pretax Margin | -612.63% |
| Profit Margin | n/a |
| EBITDA Margin | -214.86% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DSE:CENTRALPHL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.29% |
| Shareholder Yield | 1.29% |
| Earnings Yield | -2.04% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on November 26, 2018. It was a forward split with a ratio of 1.05.
| Last Split Date | Nov 26, 2018 |
| Split Type | Forward |
| Split Ratio | 1.05 |
Scores
DSE:CENTRALPHL has an Altman Z-Score of 1.33. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.33 |
| Piotroski F-Score | n/a |